Connect Biopharma (CNTB) Institutional Ownership $1.95 -0.20 (-9.49%) As of 02:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Connect Biopharma (NASDAQ:CNTB)CurrentInstitutional OwnershipPercentage58.72%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$567.01KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$322.55K Get CNTB Insider Trade Alerts Want to know when executives and insiders are buying or selling Connect Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNTB Institutional Buying and Selling by Quarter Connect Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/12/2025 XTX Topco Ltd28,862$29K0.0%N/A0.052% 8/12/2025 AlphaCore Capital LLC80,000$78K0.0%N/A0.144% 8/11/2025 BML Capital Management LLC1,821,558$1.79M1.4%-13.0%3.278% 7/29/2025 Koa Wealth Management LLC49,600$49K0.0%N/A0.089% 2/13/2025 Renaissance Technologies LLC134,697$186K0.0%-23.2%0.244% 2/3/2025Callan Capital LLC80,000$110K0.0%+91.3%0.145% 1/27/2025 Choreo LLC160,867$204K0.0%N/A0.291% 1/24/2025 Catalina Capital Group LLC47,867$66K0.0%N/A0.087% 11/5/2024 BML Capital Management LLC2,093,232$3.01M1.8%+2.4%3.789% 8/9/2024 Renaissance Technologies LLC212,300$323K0.0%-11.5%0.385% Get the Latest News and Ratings for CNTB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Connect Biopharma and its competitors with MarketBeat's FREE daily newsletter. 7/17/2024 Keudell Morrison Wealth Management32,200$49K0.0%+63.5%0.058% 5/7/2024 Keudell Morrison Wealth Management19,700$34K0.0%+75.9%0.036% 1/30/2024 BML Capital Management LLC2,061,438$2.43M1.8%N/A3.743% 8/15/2023Kynam Capital Management LP535,005$603K0.1%-27.7%0.972% 11/14/2022Boothbay Fund Management LLC26,867$35K0.0%-65.5%0.049% 8/16/2022DAFNA Capital Management LLC250,000$218K0.1%N/A0.454% 5/13/2022Kynam Capital Management LP227,759$688K0.2%N/A0.414% 2/22/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022 DLD Asset Management LP121,707$627K0.0%N/A0.212% 2/15/2022Adage Capital Partners GP L.L.C.1,250,000$6.44M0.0%N/A2.174% 2/14/2022 Altium Capital Management LP175,000$901K0.2%N/A0.304% 2/14/2022Deep Track Capital LP647,057$3.33M0.2%N/A1.125% 2/11/2022 Ensign Peak Advisors Inc25,412$131K0.0%N/A0.044% 11/16/2021Janus Henderson Group PLC403,459$9.57M0.0%+3.1%0.702% 11/16/2021Wellington Management Group LLP1,145,177$27.37M0.0%-25.3%1.991% 11/12/2021Vident Investment Advisory LLC10,851$263K0.0%N/A0.019% 11/9/2021BlackRock Inc.2,450,065$59.37M0.0%-0.3%4.261% 11/5/2021Daiwa Securities Group Inc.6,069$147K0.0%N/A0.011% 8/17/2021Millennium Management LLC42,856$837K0.0%+286.1%0.075% 8/17/2021Old Well Partners LLC122,431$2.39M1.1%N/A0.213% 8/16/2021RA Capital Management L.P.6,991,003$136.53M2.2%+133.7%12.157% 8/16/2021 Federated Hermes Inc.12,000$234K0.0%-70.0%0.021% 8/13/2021FMR LLC3,925,836$76.67M0.0%+23.3%6.827% 8/11/2021BlackRock Inc.2,458,132$48.01M0.0%+0.3%4.275% 8/10/2021 Citigroup Inc.1,413$28K0.0%N/A0.002% 5/18/2021Millennium Management LLC11,099$205K0.0%N/A0.019% 5/18/2021Citadel Advisors LLC245,191$4.54M0.0%N/A0.426% (Data available from 1/1/2016 forward) CNTB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNTB shares? During the previous two years, 10 institutional investors and hedge funds held shares of Connect Biopharma. The most heavily invested institutionals were BML Capital Management LLC ($1.79M), Kynam Capital Management LP ($603K), Choreo LLC ($204K), Renaissance Technologies LLC ($186K), Callan Capital LLC ($110K), AlphaCore Capital LLC ($78K), and Catalina Capital Group LLC ($66K).Learn more on Connect Biopharma's institutional investors. What percentage of Connect Biopharma's stock is owned by institutional investors? 58.72% of Connect Biopharma's stock is owned by institutional investors. Learn more on CNTB's institutional investor holdings. Which institutional investors have been buying Connect Biopharma's stock? The following institutional investors have purchased Connect Biopharma's stock in the last 24 months: BML Capital Management LLC ($2.11M), Choreo LLC ($160.87K), AlphaCore Capital LLC ($80K), Koa Wealth Management LLC ($49.60K), Catalina Capital Group LLC ($47.87K), Callan Capital LLC ($38.18K), and XTX Topco Ltd ($28.86K). How much institutional buying is happening at Connect Biopharma? Institutional investors have bought a total of 455,357 shares in the last 24 months. This purchase volume represents approximately $567.01K in transactions. Which of Connect Biopharma's major shareholders have been selling company stock? The following institutional investors have sold Connect Biopharma stock in the last 24 months: BML Capital Management LLC ($271.67K), and Renaissance Technologies LLC ($40.80K). How much institutional selling is happening at Connect Biopharma? Institutional investors have sold a total of 312,477 shares in the last 24 months. This volume of shares sold represents approximately $322.55K in transactions. Related Companies ITOS Institutional Ownership KOD Institutional Ownership KMDA Institutional Ownership ERAS Institutional Ownership CGEM Institutional Ownership CMPS Institutional Ownership PRTA Institutional Ownership TECX Institutional Ownership PRTC Institutional Ownership CYRX Institutional Ownership This page (NASDAQ:CNTB) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access